Champions Oncology (CSBR) Gross Profit (2017 - 2026)
Champions Oncology (CSBR) posted quarterly Gross Profit of $7.0 million for Q2 2026, up 38.18% year-over-year from $5.1 million in Q2 2025, and down 9.06% quarter-over-quarter from $7.7 million in Q1 2026.
Champions Oncology (CSBR) Gross Profit (2017 - 2026) Analysis & Trends
Champions Oncology's Gross Profit history runs 10 years deep, the most recent figure standing at $7.0 million for Q2 2026.
- In Q2 2026, Gross Profit rose 38.18% year-over-year to $7.0 million; the TTM figure through Apr 2026 stood at $28.5 million (changed 0.12% YoY), while the FY2026 annual figure was $28.5 million, changed 0.11% from the prior year.
- Gross Profit for Q2 2026 stood at $7.0 million, down from $7.7 million in the prior quarter.
- The five-year high for Gross Profit was $10.4 million in Q1 2025, with the low at $4.2 million in Q1 2024.
- The 5-year median for Gross Profit is $6.7 million (2022), against an average of $6.4 million.
- The sharpest annual moves came in 2023 and 2025: Gross Profit declined 27.54% in 2023, then jumped 149.93% in 2025.
- Champions Oncology's Gross Profit stood at $6.8 million in 2022, then slipped by 27.54% to $5.0 million in 2023, then climbed by 22.32% to $6.1 million in 2024, then climbed by 28.25% to $7.8 million in 2025, then retreated by 9.62% to $7.0 million in 2026.
- Business Quant data shows CSBR's Gross Profit at $7.0 million in Q2 2026, $7.7 million in Q1 2026, and $7.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 7.03 Mn |
| Apr 30, 2026 | 7.03 Mn |
| Jan 31, 2026 | 7.73 Mn |
| Jan 31, 2026 | 7.73 Mn |
| Oct 31, 2025 | 7.77 Mn |
| Oct 31, 2025 | 7.77 Mn |
| Jul 31, 2025 | 6.00 Mn |
| Jul 31, 2025 | 6.00 Mn |
| Apr 30, 2025 | 5.08 Mn |
| Apr 30, 2025 | 5.08 Mn |
| Jan 31, 2025 | 10.42 Mn |
| Jan 31, 2025 | 10.42 Mn |
| Oct 31, 2024 | 6.06 Mn |
| Oct 31, 2024 | 6.06 Mn |
| Jul 31, 2024 | 6.99 Mn |
| Jul 31, 2024 | 6.99 Mn |
| Apr 30, 2024 | 6.75 Mn |
| Apr 30, 2024 | 6.75 Mn |
| Jan 31, 2024 | 4.17 Mn |
| Jan 31, 2024 | 4.17 Mn |